文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

2021年5月加利福尼亚州立监狱Alpha B.1.1.7变异株暴发中的间接疫苗有效性

Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
PubMed 文献 · Vaccine · 2024-04-06

研究调查2021年5月14日至6月22日加利福尼亚州立监狱733名居民暴露于Alpha变异株的疫情,46.9%接种疫苗(93.6%为两剂mRNA-1273)。任何疫苗至少一剂的疫苗有效性为86%(95%CI:75%-97%)对抗PCR确诊感染。未接种居民所在楼栋接种率越高,其PCR确诊和有症状感染率越低;

要点

  • 任何疫苗至少一剂对PCR确诊感染的疫苗有效性为86%(95%CI:75%-97%)。
  • 未接种居民楼栋接种率越高,PCR确诊和有症状感染率越低。

核心结论

  • 在此次Alpha变异株暴发中,接种疫苗提供了直接和可能的间接保护,抵御SARS-CoV-2感染和有症状COVID-19。
  • 结果支持监狱环境中疫苗接种率对减轻暴发和重症的重要性,以及政策和感染应对中考虑社区疫苗接种水平。

研究设计与样本

  • 研究为队列研究,纳入733名推测在2021年5月14日至6月22日暴露的州立监狱居民。
  • 使用Cox比例风险回归估计暴发开始时任何疫苗至少一剂的疫苗有效性。

主要发现

  • 46.9%(n=344)接种疫苗,其中93.6%(n=332)接种两剂mRNA-1273。
  • 共发现92例PCR阳性病例,其中14例(14.5%)发生在接种mRNA-1273的居民中,无病例需住院。
  • 收集的9株分离株均属于Alpha(B.1.1.7)变异株。
  • 任何疫苗至少一剂对PCR确诊感染的疫苗有效性为86%(95%CI:75%-97%),对有症状感染结果相似。

关键数值与推荐

  • 任何疫苗至少一剂对PCR确诊感染的疫苗有效性为86%(95%CI:75%-97%)。

临床怎么用

  • 结果支持监狱环境中疫苗接种率对减轻暴发和重症的重要性。
  • 政策和感染应对中应考虑社区疫苗接种水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Incarcerated populations experienced high rates of SARS-CoV-2 infection and death during early phases of the COVID-19 pandemic. To evaluate vaccine effectiveness in the carceral context, we investigated the first outbreak of COVID-19 in a California state prison following widespread rollout of vaccines to residents in early 2021. We identified a cohort of 733 state prison residents presumed to be exposed between May 14 and June 22, 2021. 46.9 % (n = 344) were vaccinated, primarily with two doses of mRNA-1273 (n = 332, 93.6 %). In total, 92 PCR-positive cases were identified, of which 14 (14.5 %) occurred among mRNA-1273 vaccinated residents. No cases required hospitalization. All nine isolates collected belonged to the Alpha (B.1.1.7) variant. We used Cox proportional hazard regression to estimate vaccine effectiveness for at least one dose of any vaccine at the start of the outbreak. Vaccine effectiveness was 86 % (95 % CI: 75 %-97 %) against PCR-confirmed infection, with similar results for symptomatic infection. Higher rates of building-level vaccine uptake were associated with a lower overall rate of PCR-confirmed infection and symptomatic infection among unvaccinated residents. Among unvaccinated residents who lived in shared cells at the time of presumed exposure, exposure to a vaccinated cellmate was associated with a 38% (95% CI: 0.37, 1.04) lower hazard rate of PCR-confirmed infection over the study period. In this outbreak involving the Alpha SARS-CoV-2 variant, vaccination conferred direct and possibly indirect protection against SARS-CoV-2 infection and symptomatic COVID-19. Our results support the importance of vaccine uptake in mitigating outbreaks and severe disease in the prison setting and the consideration of community vaccination levels in policy and infection response.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Archer H, McCoy SI, Sears D, et al. Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021. Vaccine. 2024. PMID: 38584059. doi:10.1016/j.vaccine.2024.03.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。